Market News How it works Learn FAQ
| RCT 0.0827 8.67% | NU 12.59 -16.95% | EWZ 34.15 -19.82% | BBD 2.93 -28.01% | TGL 0.2427 9.57% | AZTR 1.53 113.99% | ITUB 7.7 -20.37% | XP 15.705 -48.36% | NVD 3.99 -4.77% | SRTM 0.3 -30.28% | WFF 0.0898 12.25% | SPCX 146.9 -0.40% | PBR 22.5 -13.99% | SHFS 0.094 -29.00% | SOXL 90.5 8.31% | INTC 90.47 4.04% | VALE 12 -3.23% | NVDA 216 2.39% | CLRO 4.97 52.92% | NOK 8.64 6.14% | JBLU 2.37 -9.71% | TSLL 10.76 10.25% | CRWV 55.19 1.76% | GCDT 0.1545 -12.27% | SOXS 47.98 -8.54% | RIG 6.53 1.87% | NWGL 0.0869 5.98% | ABEV 2.83 -14.24% | RWM 14.5 -0.34% | BITO 10.65 -1.66% | AAL 12.2 0.74% | GPUS 0.1785 5.68% | TSLG 5.38 10.47% | T 20.85 -0.38% | SGRY 23.25 47.62% | IREN 25.43 2.11% | INTR 4.68 -34.91% | SBS 4.73 -26.09% | NFLX 63.9 -2.96% | GRAB 2.71 -2.87% | TSLA 391.62 5.21% | QID 14.22 -2.27% | WULF 11.98 5.83% | TQQQ 68.43 3.23% | CIFR 7.71 -2.90% | RBNE 0.17 -10.53% | SID 0.9118 -22.73% | SPDN 8.5 -0.47% | VZ 43.1 -3.49% | LUCD 0.5007 21.82%
TSTurnstone Biologics Corp. logo

Turnstone Biologics Corp. (TSBX)

NASDAQ Global Market · Currency in USD
$0.36 ▲ +0.00 (+0.00%)
At close: Aug 11, 4:00 PM ET. Market closed.

Summary

Previous Close
$0.36
Open
$0.36
Day's Range
$0.36 – $0.36
52 Week Range
$0.29 – $2.26
Volume
283,774
Avg. Volume
404,925
Market Cap
$8.21M
Beta (5Y Monthly)
1.37
PE Ratio (TTM)
--
EPS (TTM)
-$3.07
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$0.50

Profile: Turnstone Biologics Corp.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
14
CEO
Sammy J. Farah

Turnstone Biologics Corp. is a clinical-stage biotechnology firm dedicated to developing therapeutic and curative treatments for patients battling solid tumor cancers. Its leading investigational drug, TIDAL-01, is currently undergoing Phase 1 clinical trials for indications such as breast cancer, colorectal cancer, and uveal melanoma. This compound is also being assessed in an investigator-sponsored trial to address cutaneous and non-cutaneous melanomas.

Earnings

DateEst.Actual
Aug 8, 2025-$0.16-$0.24Miss
May 8, 2025-$0.26-$0.51Miss
Mar 28, 2025-$0.69-$0.56Beat
Nov 12, 2024-$0.87-$0.74Beat
Aug 14, 2024-$0.84-$0.92Miss
May 13, 2024-$0.78-$0.85Miss

Analyst view

Consensus price target
$0.50 ▲ +40.8%
Range $0.50 – $0.50
Rating: Buy
Buy 50% · Hold 50% · Sell 0%

Get free alerts on TSBX and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.